Search Results - "Gomon, Yu M"

Efficacy of alectinib in comparison with lorlatinib in patients with ALK-positive non-small cell lung cancer: pharmacoeconomic study by Kolbin, A. S., Gomon, Yu. M., Proskurin, M. A., Balykina, Yu. E.

“…Objective: to evaluate the clinical and economic effectiveness of alectinib in comparison with lorlatinib in adult patients with advanced anaplastic lymphoma…”
Get full text

A Systematic Review with Meta-Analysis and Indirect Comparison of the Effectiveness of COVID-19 Anti-Interleukin Therapy by Yu. M. Gomon, A. S. Kolbin, A. M. Fahrutdinova, T. A. Usmanova, F. M. Sultanova, Yu. E. Balykina

“…Aim. Evaluation of the effectiveness of anti-interleukin drugs used in the pathogenetic therapy of COVID-19 in relation to the relative risks of 28-day…”
Get full text

Factors associated with adverse outcome among hospitalized patients with moderate to severe COVID-19 by Mishinova, S. A., Gomon, Yu. M., Kolbin, A. S., Verbitskaya, E. V., Galimov, T. I.

“…Aims. To consider factors associated with adverse outcome among hospitalized patients with moderate and severe COVID-19. Materials and methods . Data from 345…”
Get full text

Approaches to Assessing the Safety of Medicines during the COVID-19 Pandemic Using the Example of Azithromycin by Gomon, Yu. M., Kasimova, A. R., Kolbin, A. S., Strizheletsky, V. V., Ivanov, I. G., Mazurenko, S. O.

“…Most of the medicines used to treat the novel coronavirus infection (COVID-19) are either approved under an accelerated procedure or not approved for the…”
Get full text

A systematic review of real-world clinical practice data in COVID-19: non-interventional studies by Mishinova, S. A., Gomon, Yu. M., Kolbin, A. S., Strizheletsky, V. V., Ivanov, I. G.

“…Introduction . As defined by the Food and Drug Administration, real-world data (RWD) is data related to a patient's health and/or health care delivery, usually…”
Get full text

The real practice of clinical and economic research of drugs included in the Federal Program of High-Cost Nosologies by Kolbin, A. S., Gomon, Yu. M., Kasimova, A. R., Kurylev, A. A., Bem, A. E.

“…Objective : to assess the compliance of the actual practice of conducting clinical and economic research with the requirements applicable in the Russian…”
Get full text

Efficiency of Levilimab in patients with moderate and severe COVID-19 by Gomon, Yu. M., Strizheletsky, V. V., Ivanov, I. G., Balykina, Yu. E., Ermolyev, M. V., Kolbin, A.  S., Livshits, M. V., Usmanova, T.  A., Fakhrutdinova, A. M., Konstantinova, Yu. S. , Gubanov, A. P.

“…Objective: evaluation of the clinical and economic efficiency of using Levilimab in the treatment of moderate and severe COVID-19 based on real world data…”
Get full text

Socioeconomic and global burden of COVID-19 by Kolbin, A. S., Gomon, Yu. M., Balykina, Yu. E., Belousov, D. Yu, Strizheletskiy, V. V., Ivanov, I. G.

“…Relevance . Assessment of the burden of disease provides information on the economic consequences of the disease, allows you to assess the social significance,…”
Get full text

Cystic fibrosis as a social-economic burden by Kolbin, A. S., Gomon, Yu. M., Karpov, O. I., Balykina, Yu. E., Proskurin, M. A.

“…Cystic fibrosis (CF) is a chronic genetic disease with social significant weight because it influences on social humanitarian part of health and on sources of…”
Get full text

Socio-economic burden of COVID-19 in the Russian Federation by Kolbin, A. S., Belousov, D. Yu, Gomon, Yu. M., Balykina, Yu. E., Ivanov, I. G.

“…Purpose. Assessment of the socio-economic burden of COVID-19 in the Russian Federation (RF). Materials and methods. Identification and assessment of direct…”
Get full text

Piperacillin-tazobactam: prospects for use in real-world practice by Yu. M. Gomon

“…A review of the literature concerning the efficacy and safety of combined anti-pseudomonas protected ureidopenicillin piperacillin/tazobactam usage. Randomized…”
Get full text

Clinical and economic analysis of Reslizumab use in the treatment of patients with severe allergic eosinophilic asthma by Kolbin, A S, Avdeev, S N, Zhuravleva, M V, Gomon, Yu M, Balykina, Yu E, Matveyev, N V, Proskurin, M A, Fedosenko, S V

“…Asthma is a heterogeneous chronic disease of airways. One of its endotypes is eosinophilic asthma, accompanied by both peripheral blood and airway…”
Get full text

ANALYSIS OF CONSUMPTION OF ANTIBACTERIAL DRUGS FOR SYSTEMIC USE IN HOSPITALS OF SAINT PETERSBURG IN 2014–2015 by Gomon, Yu. M., Kurylev, A. A., Kolbin, A. S., Proskurin, M. A., Ivanov, I. G., Sidorenko, S. V., Arepieva, M. A., Sokolov, A. V.

“…Introduction . The overuse of antimicrobial agents, and poor adherence to infection control measures are leading factors in the development of bacterial…”
Get full text

Modeling microbial drug-resistance: from mathematics to pharmacoeconomics by Gomon, Yu. M., Arepyeva, M. A., Balykina, Yu. E., Kolbin, A. S., Kurylev, A. A., Proskurin, M. A., Sidorenko, S. V.

“…Complicated intra-abdominal infection (IAI) requires increased health care expenditures and additional resources to compensate for an ineffective starting…”
Get full text

PROBLEMS OF COMPLICATED INTRA-ABDOMINAL INFECTION’S ANTIBACTERIAL TREATMENT IN MULTIDISCIPLINARY HOSPITALS by Gomon, Yu. M., Kolbin, A. S., Balykina, Yu. E., Arepyeva, M. A., Sidorenko, S. V., Strizheletskiy, V. V., Ivanov, I. G., Lobzin, Yu. V., Grinenko, О. A.

“…The objective is to assess the economic efficiency of the current practice of complicated IAI (intra-abdominal infections) treatment with antibiotics compared…”
Get full text

ECONOMIC ASSESSMENT OF THE EFFECTIVENESS AND SAFETY OF THE COMMONLY PRACTICED PERIOPERATIVE ANTIBIOTIC PROPHYLAXIS (BASED ON AN EARLIER EPIDEMIOLOGICAL SURVEY OF MULTIDISCIPLINARY HOSPITALS) by Gomon, Yu. M., Kolbin, A. S., Sidorenko, S. V., Kuzhel’, A. M., Repina, A. V., Lobzin, Yu. V., Balykina, Yu. E.

“…A survey conducted in four hospitals located in the city of St. Petersburg revealed that the commonly used perioperative antibiotic prophylaxis (PAP) did not…”
Get full text

Drug utilization research at the individual level as the main concept of pharmacoepidemiology by S. M. Mukhina, M. I. Baranova, Yu. M. Gomon

“…Pharmacoepidemiological  studies  are  necessary  to  improve  the  system  of  rational  use  of  drugs  and  to  identify  the  most problematic areas. Such…”
Get full text

Socio-economic burden of chronic graft-versus-host disease after allogenic bone marrow transplantation by Kolbin, A. S., Gomon, Yu. M., Proskurin, M. A., Balykina, Ju. E.

“…Aim . Chronic graft-versus-host disease (crGVHD) socio-economic burden assessment in the Russian Federation. Materials and methods . The assessment was…”
Get full text

Adverse drug events among hospitalized COVID-19 patients. Experience with the Global Trigger Tool by Mishinova, S. A., Kolbin, A. S., Verbitskaya, E. V., Alekseeva, N. P., Gomon, Yu. M.

“…The Global Trigger Tool is a reliable method for detecting adverse events, demonstrating positive predictive value and significant sensitivity among patients…”
Get full text

Economic efficiency of long-term oxygen therapy in patients with chronic lung diseases and severe chronic hypoxemia by Gomon, Yu.M., Titova, O.N., Kolbin, A.S., Kuzubova, N.A., Balykina, Yu.E.

“…Background: long-term oxygen therapy (LTOT) for chronic lung diseases associated with chronic hy-poxemia is effective in terms of increasing life expectancy…”
Get full text